The FDA regulates software used for medical devices through stringent guidelines that ensure patient safety and efficacy. Before a device can enter the market, manufacturers must submit evidence demonstrating that their software meets specific regulatory standards. This includes conducting clinical trials to validate the software's performance and reliability. Post-market surveillance is also essential, as the FDA monitors reported issues and may require updates or recalls if safety concerns arise. Such regulations are critical for maintaining the integrity of healthcare technologies and protecting public health.